Avant Brands (AVNT) Investor presentation summary

Company overview and market presence

• Operates four licensed indoor cannabis cultivation facilities with about 180 employees and over $41 million in annual sales.

• Recognized as one of Canada's fastest-growing companies, ranked 138th by The Globe & Mail in 2025.

• Distributes through domestic recreational, export, domestic B2B, and medical channels, with products available across Canada and in international markets like Israel, Australia, and Germany.

• Holds GACP and ICANN-GAP certifications for major facilities, supporting international exports.

Financial performance and highlights

• Achieved $9.2 million in sales and generated $1.7 million net cash from operations in the first half of 2026.

• Reported a year-to-date adjusted EBITDA of $(1.9) million for the same period.

• Gross sales grew from $22.6M in 2022 to $41.3M in 2025, with net sales reaching $35.9M in 2025.

• Gross margin peaked at $16.2M in 2024 before declining to $7.7M in 2025.

• Listed among the top 25 undervalued TSX stocks by The Globe and Mail.

Cultivation and product quality

• Focuses on premium, handcrafted cannabis using exclusive genetics and meticulous post-harvest techniques.

• Indoor cultivation model enables higher quality and premium pricing, offsetting higher production costs.

• Facilities feature advanced environmental controls and are purpose-built for optimal cannabis production.

• Portfolio includes over 75 unique cultivars, emphasizing rare and exotic strains.